These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 25964330)

  • 1. Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.
    Tsai SY; Pokrass MJ; Klauer NR; Nohara H; Su TP
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6742-7. PubMed ID: 25964330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myristic acid hitchhiking on sigma-1 receptor to fend off neurodegeneration.
    Ciesielski J; Su TP; Tsai SY
    Receptors Clin Investig; 2016; 3(1):. PubMed ID: 27077074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation.
    Zhao D; Zhou Y; Huo Y; Meng J; Xiao X; Han L; Zhang X; Luo H; Can D; Sun H; Huang TY; Wang X; Zhang J; Liu FR; Xu H; Zhang YW
    Cell Death Differ; 2021 Jan; 28(1):337-348. PubMed ID: 32908202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.
    Minegishi S; Asada A; Miyauchi S; Fuchigami T; Saito T; Hisanaga S
    Biochemistry; 2010 Jul; 49(26):5482-93. PubMed ID: 20518484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
    Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
    J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
    Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
    J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
    Crespo-Biel N; Canudas AM; Camins A; Pallàs M
    Neurochem Int; 2007 Jan; 50(2):435-42. PubMed ID: 17116346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK5 activator protein p25 preferentially binds and activates GSK3β.
    Chow HM; Guo D; Zhou JC; Zhang GY; Li HF; Herrup K; Zhang J
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4887-95. PubMed ID: 25331900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
    Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
    J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.
    Cruz JC; Tseng HC; Goldman JA; Shih H; Tsai LH
    Neuron; 2003 Oct; 40(3):471-83. PubMed ID: 14642273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic distribution of CDK5 mRNA and p35 mRNA, and a glutamate-responsive increase of CDK5/p25 complex contribute to tau hyperphosphorylation.
    Tanaka T; Ohashi S; Takashima A; Kobayashi S
    Biochim Biophys Acta Gen Subj; 2022 Jul; 1866(7):130135. PubMed ID: 35358667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
    Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
    J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpain inhibitor inhibits p35-p25-Cdk5 activation, decreases tau hyperphosphorylation, and improves neurological function after spinal cord hemisection in rats.
    Hung KS; Hwang SL; Liang CL; Chen YJ; Lee TH; Liu JK; Howng SL; Wang CH
    J Neuropathol Exp Neurol; 2005 Jan; 64(1):15-26. PubMed ID: 15715081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p35/p25 is not essential for tau and cytoskeletal pathology or neuronal loss in Niemann-Pick type C disease.
    Hallows JL; Iosif RE; Biasell RD; Vincent I
    J Neurosci; 2006 Mar; 26(10):2738-44. PubMed ID: 16525053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
    Hallows JL; Chen K; DePinho RA; Vincent I
    J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.